“The pressures faced by businesses in the pharmaceutical and medical sector can make it difficult for leaders to establish the right direction to take.”
Jennifer Johnston
Contact JenniferIn the ever-changing landscape of the pharmaceutical and medical sector, the demand for businesses to adapt and evolve in order to provide the best patient outcomes can be tough. Working closely with each of our clients, we offer pharmaceutical management consulting advice on how to tackle the challenges and complexities that are inherent in this sector; an industry integral to all our lives.
How should you respond when confronted with the demands of the intensifying competition, the disruptive influence of technology or the rise of counterfeiting?
What should you change, keep and invest in when confronted by the increasingly high costs of research and development in an ever more stringent regulatory environment?
Without a clearly defined route, there can be no end of pitfalls and wrong turns for decision-makers to avoid.
The Berkeley Partnership supports pharmaceutical and medical businesses navigating through complexity, towards successful outcomes. Whether it’s helping you to align on direction and inject some fresh perspective when setting a strategy or harnessing new technologies to bring about a step change in your operating model – our involvement is designed to put your interests first and help build your internal capability to drive long-lasting change.
Healthcare and NHS
We tend to choose Berkeley for global and complex projects which are difficult. Complexity doesn’t always presuppose difficulty. Difficulty tends to arise under constraints such as time pressure, cultural differences/EQ, numbers and the nature of the task… I think that’s the sweet spot for Berkeley.”
A Berkeley client
How do I implement technology to transform my life science business?
How do I best protect my pharmaceutical organisation’s intellectual property in the face of increased counterfeiting?
How do I evaluate my R&D outputs to assure my future product portfolio?
How can I develop and recruit talent in the pharma industry post-Brexit and Covid?
How can I ensure my pharmaceutical business is secure from cyber-attack?